Ten of the 250 non-synonymous mutations have been previously identified in cancer samples (Table 1), among these, three PTEN mutations in two patients were previously found in gliomas and three TP53 mutations in one patient were previously identified in various cancer types [38]. This evidence concerns the gene PTEN and glioma.